Streetbeat News

Revenues

SYRA

Syra Health Corp. (NASDAQ:SYRA) has secured a five-year, $4.75 million contract from the District of Columbia's Department of Behavioral Health (DBH). The contract will enable Syra Health to support DBH's mental health initiatives, including its Supported Employment Program and Comprehensive Psychiatric Emergency Program.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 1:06 pm

AAPL

TSM

Taiwan Semiconductor Manufacturing Company (TSMC) is expected to report a 10% revenue decline this year due to insufficient iPhone chip sales to balance the fall in other chip orders, according to industry sources.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 12:57 pm

MXCT

MaxCyte announced a year-over-year decrease of 25 to 27 percent in preliminary Q3 total revenue, leading to a drop in its share price.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 12:54 pm

COST

FANG

OKE

WMT

On CNBC's 'Halftime Report Final Trades', analysts discussed ONEOK, Inc. (OKE), Walmart Inc. (WMT), Costco Wholesale Corporation (COST), and Diamondback Energy, Inc. (FANG). ONEOK was initiated with an Underperform rating by Pickering Energy Partners. Walmart is increasing third-party seller activity for the holiday season. Costco reported September retail month net sales of $22.75 billion. Diamondback Energy had its price target raised from $191 to $198 by UBS.

Portfolio Pulse from Priya Nigam

October 05, 2023 | 12:47 pm

COSM

Cosmos Health Inc. (NASDAQ:COSM) CEO Greg Siokas has issued a letter to shareholders outlining the company's strategic plans and financial outlook. The company has introduced its 2026 guidance, expecting to achieve over $180M in gross annual revenue and EBITDA in excess of $20M. The company has completed three acquisitions in 2023 and is making progress in R&D. The company is also considering spinning off its R&D division into a standalone, publicly listed biotech company. The CEO has invested more than $15M since inception, including almost $1M YTD.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 12:43 pm

DYAI

Dyadic International (NASDAQ:DYAI) has entered into a research collaboration agreement with the Vaccine and Immunotherapy Center (VIC) at Massachusetts General Hospital and Voltron Therapeutics. The collaboration is part of a $5.88 million award from the U.S. Department of Defense to VIC for the development of a Self-Assembling Vaccine (SAV) Platform for rapid production of prophylactic vaccines. Dyadic's proprietary C1 protein production platform will be used to express vaccine antigens for influenza A and other infectious diseases. If successful, this collaboration could provide a commercial opportunity for Dyadic to receive revenues from products brought to market.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 12:42 pm

LW

Lamb Weston has increased its revenue outlook for FY24 from $6.7B-$6.9B to $6.8B-$7B, compared to the estimated $6.83B.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 12:35 pm

LPTH

LightPath Technologies has secured a renewal order worth $3.4 million, marking a 36% increase from the initial order.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 12:35 pm

VFS

Vinfast CEO announced that the company's US dealerships will be open by the end of the year. He also expects the company to break even within two years and to be running its Vietnam factory at full capacity within the same timeframe.

Portfolio Pulse from Bill Haddad

October 05, 2023 | 12:31 pm

SPY

The USA trade balance for August was reported at -$58.30 billion, better than the estimated -$62.30 billion and the prior figure of -$64.70 billion.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 12:30 pm